Rezolute
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
HOGENHUIS WLADIMIR director
 Common Stock 4,259 $4.7 $20,017
Purchase
HOGENHUIS WLADIMIR director
 Common Stock 4,815 $4.15 $19,982
Purchase
ROBERTS BRIAN KENNETH officer: Chief Medical Officer
 Common Shares 300 $3.96 $1,188
Purchase
ROBERTS BRIAN KENNETH officer: Chief Medical Officer
 Common Shares 4,000 $3.91 $15,640
Purchase
ROBERTS BRIAN KENNETH officer: Chief Medical Officer
 Common Shares 3,000 $3.91 $11,724
Purchase
ROBERTS BRIAN KENNETH officer: Chief Medical Officer
 Common Shares 300 $3.97 $1,191
Purchase
EVANS DARON officer: CFO
 Common Shares 40,000 $4.04 $161,560
Purchase
EVANS DARON officer: CFO
 Common Shares 451 $3.5 $1,579
Purchase
EVANS DARON officer: CFO
 Common Shares 2,942 $3.23 $9,503
Purchase
EVANS DARON officer: CFO
 Common Shares 58 $2.85 $165
Purchase
ROBERTS BRIAN KENNETH officer: Chief Medical Officer
 Common Shares 500 $2.55 $1,275
Purchase
EVANS DARON officer: CFO
 Common Shares 20,000 $1.69 $33,840
Purchase
ROBERTS BRIAN KENNETH officer: Chief Medical Officer
 Common Shares 10,000 $1.88 $18,800
Purchase
EVANS DARON officer: CFO
 Common Shares 50,000 $1.93 $96,350
Purchase
ROBERTS BRIAN KENNETH officer: Chief Medical Officer
 Common Shares 500 $1.85 $925
Purchase
KIM YOUNG-JIN director
 Common Shares 36,503 $1.91 $69,867
Purchase
ROBERTS BRIAN KENNETH officer: Chief Medical Officer
 Common Shares 500 $1.85 $925
Purchase
ELAM NEVAN C director, officer: CEO
 Common Shares 5,000 $1.68 $8,400
Purchase
ROBERTS BRIAN KENNETH officer: Chief Medical Officer
 Common Shares 2,000 $1.7 $3,400
Purchase
ROBERTS BRIAN KENNETH officer: Chief Medical Officer
 Common Shares 6,000 $1.69 $10,140
Purchase
ROBERTS BRIAN KENNETH officer: Chief Medical Officer
 Common Shares 7,000 $1.31 $9,142
Purchase
EVANS DARON officer: CFO
 Common Shares 41,900 $1.3 $54,428
Purchase
EVANS DARON officer: CFO
 Common Shares 4,500 $1.37 $6,165
Purchase
ROBERTS BRIAN KENNETH officer: Sr VP, Clinic Developm..
 Common Stock 300 $2.95 $884
Purchase
ROBERTS BRIAN KENNETH officer: Sr VP, Clinic Developm..
 Common Stock 200 $2.86 $572
Purchase
ROBERTS BRIAN KENNETH officer: Sr VP, Clinic Developm..
 Common Stock 1,000 $3.41 $3,407
Purchase
HOGENHUIS WLADIMIR director
 Common Stock 25,000 $3.8 $95,000
Purchase
ROBERTS BRIAN KENNETH officer: Sr VP, Clinic Developm..
 Common Stock 21,052 $3.8 $79,998
Purchase
LABRUCHERIE GIL M director
 Common Stock 52,631 $3.8 $199,998
Purchase
LABRUCHERIE GIL M director
 Common Stock 52,631 $3.8 $199,998
Purchase
HOGENHUIS WLADIMIR director
 Common Stock 7,693 $6.5 $50,005
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 2,500 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A
Purchase
HANDOK, INC. 10 percent owner
 Common Shares 125,000 N/A N/A

Showing 1 to 50 of 130 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: